Advertisement

Overactive Bladder

  • Lorenzo Masieri
  • Chiara Cini
  • Maria Taverna
Chapter
Part of the Urodynamics, Neurourology and Pelvic Floor Dysfunctions book series (UNPFD)

Abstract

Detrusor overactivity is the most common voiding dysfunction in children. This condition is also known as overactive bladder (OAB), urge syndrome, hyperactive bladder syndrome, persistent infantile bladder, or detrusor hypertonia [1]. Idiopathic OAB is defined by the International Continence Society (ICS) as a complex symptom of urinary urgency, which may or may not be associated with urgency urinary incontinence, urinary frequency, and nocturia in the absence of pathological or metabolic factors [2]. As the OAB symptomatology is concerned, the International Children’s Continence Society (ICCS) states that Urgency incontinence is often also present, as the increased voiding frequency, but these symptoms are not necessary prerequisites for the use of the term OAB [3]. The OAB in children is characterized by involuntary detrusor contractions and urethral instability [4]. The etiology has been variously ascribed to maturation delay, prolongation of infantile bladder behavior, or shortening of acquired toilet-training habits [5]. Early diagnosis and appropriate treatment could affect upper urinary tract function and drainage and ultimate bladder functions.

References

  1. 1.
    Sarica K, Yagci F, Erturhan S, Yurtseven C. Conservative management of overactive bladder in children: evaluation of clinical and urodynamic results. J Pediatr Urol. 2006;2:34–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21:167–78.CrossRefPubMedGoogle Scholar
  3. 3.
    Neveus T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the standardisation Committee of the International Children’s continence society. J Urol. 2006;176:314–24.CrossRefPubMedGoogle Scholar
  4. 4.
    Bauer SB. Special considerations of the overactive bladder in children. Urology. 2002;60:43–8; discussion 49.CrossRefPubMedGoogle Scholar
  5. 5.
    Fernandes E, Vernier R, Gonzalez R. The unstable bladder in children. J Pediatr. 1991;118:831–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Nijman RJM, Bower W, Butler U. Diagnosis and management of urinary incontinence and encopresis in children. Inc. 2005;2:965.Google Scholar
  7. 7.
    Chung JM, Lee SD, Kang DI, et al. Prevalence and associated factors of overactive bladder in Korean children 5-13 years old: a nationwide multicenter study. Urology. 2009;73:63–9.  https://doi.org/10.1016/j.urology.2008.06.063.CrossRefPubMedGoogle Scholar
  8. 8.
    Hoebeke P, Van Laecke E, Van Camp C, et al. One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int. 2001;87:575–80.CrossRefPubMedGoogle Scholar
  9. 9.
    Bloom DA, Seeley WW, Ritchey ML, McGuire EJ. Toilet habits and continence in children: an opportunity sampling in search of normal parameters. J Urol. 1993;149:1087–90.CrossRefPubMedGoogle Scholar
  10. 10.
    Himsl KK, Hurwitz RS. Pediatric urinary incontinence. Urol Clin North Am. 1991;18:283–93.PubMedGoogle Scholar
  11. 11.
    Hellström AL, Hanson E, Hansson S, et al. Micturition habits and incontinence in 7-year-old Swedish school entrants. Eur J Pediatr. 1990;149:434–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Dator DP, Hatchett L, Dyro FM, et al. Urodynamic dysfunction in walking myelodysplastic children. J Urol. 1992;148:362–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Peters CA, Bolkier M, Bauer SB, et al. The urodynamic consequences of posterior urethral valves. J Urol. 1990;144:122–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Kass EJ, Diokno AC, Montealegre A. Enuresis: principles of management and result of treatment. J Urol. 1979;121(6):794.CrossRefPubMedGoogle Scholar
  15. 15.
    Nørgaard JP, van Gool JD, Hjälmås K, et al. Standardization and definitions in lower urinary tract dysfunction in children. International Children’s continence society. Br J Urol. 1998;81(Suppl 3):1–16.CrossRefPubMedGoogle Scholar
  16. 16.
    Hjälmås K. Functional daytime incontinence: definitions and epidemiology. Scand J Urol Nephrol Suppl. 1992;141:39–44; discussion 45–6.PubMedGoogle Scholar
  17. 17.
    Ochoa B. The urofacial (Ochoa) syndrome revisited. J Urol. 1992;148:580–3.CrossRefPubMedGoogle Scholar
  18. 18.
    Van Arsdelen K, Wein A. Physiology of micturition. Clin Neuro-Urology. 1991:56–9.Google Scholar
  19. 19.
    Kuhtz-Buschbeck JP, van der Horst C, Pott C, et al. Cortical representation of the urge to void: a functional magnetic resonance imaging study. J Urol. 2005;174:1477–81.CrossRefPubMedGoogle Scholar
  20. 20.
    Griffiths D, Derbyshire S, Stenger A, Resnick N. Brain control of normal and overactive bladder. J Urol. 2005;174:1862–7.  https://doi.org/10.1097/01.ju.0000177450.34451.97.CrossRefPubMedGoogle Scholar
  21. 21.
    Franco I. Overactive bladder in children. Part 1: pathophysiology. J Urol. 2007;178:761–768; discussion 768.  https://doi.org/10.1016/j.juro.2007.05.014.CrossRefPubMedGoogle Scholar
  22. 22.
    Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. 1997;100:228–32.CrossRefPubMedGoogle Scholar
  23. 23.
    Miyazato M, Sugaya K, Nishijima S, et al. Rectal distention inhibits bladder activity via glycinergic and GABAergic mechanisms in rats. J Urol. 2004;171:1353–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Ustinova EE, Gutkin DW, Pezzone MA. Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides. Am J Physiol Renal Physiol. 2007;292:F123–30.CrossRefPubMedGoogle Scholar
  25. 25.
    Riegler G, Esposito I. Bristol scale stool form. A still valid help in medical practice and clinical research. Tech Coloproctol. 2001;5:163–4.CrossRefPubMedGoogle Scholar
  26. 26.
    Evans BW, Clark WK, Moore DJ, Whorwell PJ. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database Syst Rev. 2007;14:CD003960.Google Scholar
  27. 27.
    van Gool JD, de Jonge GA. Urge syndrome and urge incontinence. Arch Dis Child. 1989;64:1629–34.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Burgers R, de Jong TPVM, Visser M, et al. Functional defecation disorders in children with lower urinary tract symptoms. J Urol. 2013;189:1886–91.CrossRefPubMedGoogle Scholar
  29. 29.
    Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010;303:242–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Chen LJ, Fox KR, Haase A, Wang JM. Obesity, fitness and health in Taiwanese children and adolescents. Eur J Clin Nutr. 2006;60:1367–75.  https://doi.org/10.1038/sj.ejcn.1602466.CrossRefPubMedGoogle Scholar
  31. 31.
    Erdem E, Lin A, Kogan BA, Feustel PJ. Association of elimination dysfunction and body mass index. J Pediatr Urol. 2006;2:364–7.  https://doi.org/10.1016/j.jpurol.2006.05.002.CrossRefPubMedGoogle Scholar
  32. 32.
    Chang S-J, Chiang I-N, Lin C-D, et al. Obese children at higher risk for having overactive bladder symptoms: a community-based study. Neurourol Urodyn. 2015;34:123–7.  https://doi.org/10.1002/nau.22532.CrossRefPubMedGoogle Scholar
  33. 33.
    Weintraub Y, Singer S, Alexander D, et al. Enuresis--an unattended comorbidity of childhood obesity. Int J Obes. 2013;37:75–8.  https://doi.org/10.1038/ijo.2012.108.CrossRefGoogle Scholar
  34. 34.
    Schwartz B, Wyman JF, Thomas W, Schwarzenberg SJ. Urinary incontinence in obese adolescent girls. J Pediatr Urol. 2009;5:445–50.  https://doi.org/10.1016/j.jpurol.2009.07.005.CrossRefPubMedGoogle Scholar
  35. 35.
    Lettgen B, von Gontard A, Olbing H, et al. Urge incontinence and voiding postponement in children: somatic and psychosocial factors. Acta Paediatr. 2002;91:978–84; discussion 895–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Hoebeke P, Bower W, Combs A, et al. Diagnostic evaluation of children with daytime incontinence. J Urol. 2010;183:699–703.  https://doi.org/10.1016/j.juro.2009.10.038.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Curran MJ, Kaefer M, Peters C, et al. The overactive bladder in childhood: long-term results with conservative management. J Urol. 2000;163:574–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Fitzgerald MP, Thom DH, Wassel-Fyr C, et al. Childhood urinary symptoms predict adult overactive bladder symptoms. J Urol. 2006;175:989–93.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization Committee of the International Children’s continence society. J Urol. 2014;191:1863–1865.e13.CrossRefPubMedGoogle Scholar
  40. 40.
    Hagstroem S, Rittig N, Kamperis K, et al. Treatment outcome of day-time urinary incontinence in children. Scand J Urol Nephrol. 2008;42:528–33.CrossRefPubMedGoogle Scholar
  41. 41.
    Vijverberg MAW, Stortelder E, de Kort LMO, et al. Long-term follow-up of incontinence and urge complaints after intensive urotherapy in childhood (75 patients followed up for 16.2-21.8 years). Urology. 2011;78:1391–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Austin PF, Homsy YL, Masel JL, et al. Alpha-adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction. J Urol. 1999;162:1064–7.CrossRefPubMedGoogle Scholar
  43. 43.
    Donohoe JM, Combs AJ, Glassberg KI. Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists. J Urol. 2005;173:212–6.CrossRefPubMedGoogle Scholar
  44. 44.
    Shei Dei Yang S, Wang CC. Outpatient biofeedback relaxation of the pelvic floor in treating pediatric dysfunctional voiding: a short-course program is effective. Urol Int. 2005;74:118–22.  https://doi.org/10.1159/000083281.CrossRefPubMedGoogle Scholar
  45. 45.
    Herndon CD, Decambre M, McKenna PH. Interactive computer games for treatment of pelvic floor dysfunction. J Urol. 2001;166:1893–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Hoekx L, Wyndaele JJ, Vermandel A. The role of bladder biofeedback in the treatment of children with refractory nocturnal enuresis associated with idiopathic detrusor instability and small bladder capacity. J Urol. 1998;160:858–60.CrossRefPubMedGoogle Scholar
  47. 47.
    Groen L-A, Hoebeke P, Loret N, et al. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience. J Urol. 2012;188:1313–7.  https://doi.org/10.1016/j.juro.2012.06.039.CrossRefPubMedGoogle Scholar
  48. 48.
    Hoebeke P, Renson C, Petillon L, et al. Percutaneous electrical nerve stimulation in children with therapy resistant nonneuropathic bladder sphincter dysfunction: a pilot study. J Urol. 2002;168:2605–2607; discussion 2607–8.  https://doi.org/10.1097/01.ju.0000037424.62620.f9.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Barroso U, Tourinho R, Lordêlo P, et al. Electrical stimulation for lower urinary tract dysfunction in children: a systematic review of the literature. Neurourol Urodyn. 2011;30:1429–36.  https://doi.org/10.1002/nau.21140.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Patidar N, Mittal V, Kumar M, et al. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: a preliminary report. J Pediatr Urol. 2015;11:351.e1–6.  https://doi.org/10.1016/j.jpurol.2015.04.040.CrossRefGoogle Scholar
  51. 51.
    von Gontard A, Baeyens D, Van Hoecke E, et al. Psychological and psychiatric issues in urinary and fecal incontinence. J Urol. 2011;185:1432–6.  https://doi.org/10.1016/j.juro.2010.11.051.CrossRefGoogle Scholar
  52. 52.
    Hoebeke P, De Caestecker K, Vande Walle J, et al. The effect of botulinum-a toxin in incontinent children with therapy resistant overactive detrusor. J Urol. 2006;176:321–8.  https://doi.org/10.1016/S0022-5347(06)00301-6.CrossRefGoogle Scholar
  53. 53.
    Hassouna T, Gleason JM, Lorenzo AJ. Botulinum toxin A’s expanding role in the management of pediatric lower urinary tract dysfunction. Curr Urol Rep. 2014;15:426.  https://doi.org/10.1007/s11934-014-0426-1.CrossRefPubMedGoogle Scholar
  54. 54.
    Game X, Mouracade P, Chartier-Kastler E, et al. Botulinum toxin-a (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol. 2009;5:156–64.  https://doi.org/10.1016/j.jpurol.2009.01.005.CrossRefPubMedGoogle Scholar
  55. 55.
    Barroso UJ, Viterbo W, Bittencourt J, et al. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children. J Urol. 2013;190:673–7.  https://doi.org/10.1016/j.juro.2013.02.034.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Pediatric UrologyMeyer Pediatric HospitalFlorenceItaly

Personalised recommendations